UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010875
Receipt number R000012725
Scientific Title The effects of nefopam on remifentanil-induced pronociceptive effect in middle ear surgery
Date of disclosure of the study information 2013/06/04
Last modified on 2015/02/22 20:12:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effects of nefopam on remifentanil-induced pronociceptive effect in middle ear surgery

Acronym

The effects of nefopam on remifentanil-induced hyperalgesia

Scientific Title

The effects of nefopam on remifentanil-induced pronociceptive effect in middle ear surgery

Scientific Title:Acronym

The effects of nefopam on remifentanil-induced hyperalgesia

Region

Asia(except Japan)


Condition

Condition

middle ear surgery

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Remifentanil can cause acute opioid tolerance/hyperalgesia due to central sensitization by the activation of N-methyl-D-aspartate (NMDA) receptors, resulting in increased early postoperative pain. Therefore, we will investigate the effects of continuous infusion of nefopam, a NMDA receptor antagonist, on early postoperative pain/analgesic requirement.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Recovery profiles, visual analogue scale (VAS) for pain scores, time to first analgesic requirement/analgesic demand

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Control group will be infused with an equal amount of normal saline for 20 min with remifentanil infusion of 0.1 mcg/kg/min

Interventions/Control_2

Nefopam 40 mg mixed to normal saline 100 mL will be slowly administrated throughout 20 min with remifentanil infusion of 0.1 mcg/kg/min in nefopam group

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

25 years-old <

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

Patients aged 25-65 years with American Society of Anesthesiologists physical status of 1 or 2 who are scheduled to undergo elective middle ear surgery.

Key exclusion criteria

Patients with a history of drug abuse, renal or hepatic diseases and those taking analgesics will be excluded.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Byung Gun Lim

Organization

Guro Hospital, Korea University College of Medicine

Division name

Department of Anesthesiology and Pain Medicine

Zip code


Address

148 Gurodong-ro, Guro-gu, Seoul, Korea

TEL

82-2-2626-1437

Email

bglim9205@korea.ac.kr


Public contact

Name of contact person

1st name
Middle name
Last name Byung Gun Lim

Organization

Guro Hospital, Korea University College of Medicine

Division name

Department of Anesthesiology and Pain Medicine

Zip code


Address

148 Gurodong-ro, Guro-gu, Seoul, Korea

TEL

82-2-2626-1437

Homepage URL


Email

bglim9205@korea.ac.kr


Sponsor or person

Institute

Korea University

Institute

Department

Personal name



Funding Source

Organization

Korea University

Organization

Division

Category of Funding Organization

Outside Japan

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Korea University Guro Hospital


Other administrative information

Date of disclosure of the study information

2013 Year 06 Month 04 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

The analgesic effect of nefopam combined with low dose remifentanil in patients undergoing middle ear surgery under desflurane anesthesia: a randomized controlled trial.


Yoo JY, Lim BG, Kim H, Kong MH, Lee IO, Kim NS.

Korean J Anesthesiol. 2015 Feb;68(1):43-9. doi: 10.4097/kjae.2015.68.1.43. Epub 2015 Jan 28.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 04 Month 05 Day

Date of IRB


Anticipated trial start date

2013 Year 06 Month 07 Day

Last follow-up date


Date of closure to data entry

2013 Year 08 Month 16 Day

Date trial data considered complete

2013 Year 08 Month 19 Day

Date analysis concluded

2013 Year 08 Month 23 Day


Other

Other related information



Management information

Registered date

2013 Year 06 Month 04 Day

Last modified on

2015 Year 02 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012725